Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 92 tables and 68 figures, this 192-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Synthetic API
• Branded Synthetic API
• Generic Synthetic API
Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API
Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI
Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
Captive Manufacturing
• Branded Captive API
• Generic Captive API
Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API
By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:UK
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter’s Fiver Forces Analysis 46
3 Segmentation of Asia Pacific Market by Synthesis 50
3.1 Market Overview by Synthesis 50
3.2 Synthetic API 52
3.2.1 Branded Synthetic API 53
3.2.2 Generic Synthetic API 54
3.3 Biotech API 55
3.3.1 Biotech API by Drug Type 56
3.3.1.1 Monoclonal Antibodies 57
3.3.1.2 Recombinant Proteins 58
3.3.1.3 Vaccines 59
3.3.1.4 Other Biotech APIs 60
3.3.2 Biotech API by Category 61
3.3.2.1 Innovative Biologic API 62
3.3.2.2 Generic Biosimilar API 63
3.3.3 Biotech API by Expression Technology 64
3.3.3.1 Mammalian Expression 65
3.3.3.2 Microbial Expression 66
3.3.3.3 Yeast Expression 67
3.3.3.4 Insect Expression 68
3.3.3.5 Other Expression Technologies 69
3.4 HPAPI 70
3.4.1 Branded HPAPI 71
3.4.2 Generic HPAPI 72
4 Segmentation of Asia Pacific Market by Manufacturing Process 73
4.1 Market Overview by Manufacturing Process 73
4.2 Captive Manufacturing 75
4.2.1 Branded Captive API 76
4.2.2 Generic Captive API 77
4.3 Merchant Manufacturing 78
4.3.1 Merchant Manufacturing by Drug Type 79
4.3.1.1 Branded Merchant API 80
4.3.1.2 Generic Merchant API 81
4.3.2 Merchant Manufacturing by Drug Synthesis 82
4.3.2.1 Merchant Synthetic API 83
4.3.2.2 Merchant Biotech API 84
5 Segmentation of Asia Pacific Market by Therapeutic Application 85
5.1 Market Overview by Therapeutic Application 85
5.2 Infectious Diseases 87
5.3 Oncology 88
5.4 Ophthalmology 89
5.5 Cardiovascular Disorders 90
5.6 Central Nervous System 91
5.7 Pulmonary Disorders 92
5.8 Orthopedics 93
5.9 Other Applications 94
6 Segmentation of Asia Pacific Market by Drug Type 95
6.1 Market Overview by Drug Type 95
6.2 Branded Prescription Drugs 97
6.3 Generic Prescription Drugs 98
6.4 OTC Drugs 99
7 Asia-Pacific Market 2021-2028 by Country 100
7.1 Overview of Asia-Pacific Market 100
7.2 China 103
7.3 Japan 105
7.4 India 108
7.5 Australia 110
7.6 South Korea 112
7.7 Rest of APAC Region 114
8 Competitive Landscape 116
8.1 Overview of Key Vendors 116
8.2 New Product Launch, Partnership, Investment, and M&A 119
8.3 Company Profiles 120
AbbVie Inc. 120
Astrazeneca 122
Aurobindo Pharma Ltd. 127
BASF 130
Bayer AG 133
Boehringer Ingelheim 137
Catalent Inc. 142
Dr. Reddy's Laboratories 145
F. Hoffmann-La Roche 147
GlaxoSmithKline plc 149
Lonza Group 154
Lupin Limited 159
Merck & Co., Inc. 162
Mylan NV 165
Novartis International AG 168
Pfizer Inc. 171
Sanofi 176
Sun Pharmaceutical Industries Ltd. 179
Teva Pharmaceutical Industries Ltd. 182
Thermo Fisher Scientific 184
9 Investing in Asia Pacific Market: Risk Assessment and Management 186
9.1 Risk Evaluation of Asia Pacific Market 186
9.2 Critical Success Factors (CSFs) 189
Related Reports and Products 192
List of Tables:
Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 38
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market 42
Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 50
Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn 52
Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn 56
Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn 61
Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn 64
Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn 70
Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 73
Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn 75
Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn 79
Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn 82
Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 85
Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn 95
Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn 101
Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 104
Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 104
Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 104
Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 107
Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 107
Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 107
Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 109
Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 109
Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 109
Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 111
Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 111
Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 111
Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 113
Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 113
Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 113
Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, $ bn 115
Table 34. AbbVie Inc.: Company Snapshot 120
Table 35. AbbVie Inc.: Product Portfolio 120
Table 36. AbbVie Inc.: Revenue, 2018-2020, $ bn 121
Table 37. Astrazeneca: Company Snapshot 122
Table 38. Astrazeneca: Revenue, 2018-2020, $ bn 123
Table 39. Aurobindo Pharma Ltd.: Company Snapshot 127
Table 40. Aurobindo Pharma Ltd.: Product Portfolio 128
Table 41. BASF: Company Snapshot 130
Table 42. BASF: Business Segmentation 131
Table 43. BASF: Revenue by Region 131
Table 44. Bayer AG: Company Snapshot 133
Table 45. Bayer AG: Business Segmentation 134
Table 46. Bayer AG: Revenue, 2018-2020, € bn 134
Table 47. Boehringer Ingelheim: Company Snapshot 137
Table 48. Boehringer Ingelheim: Business Segmentation in 2019 138
Table 49. Boehringer Ingelheim: Product Portfolio 138
Table 50. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 139
Table 51. Boehringer Ingelheim: Revenue by Region in 2019 139
Table 52. Catalent Inc.: Company Snapshot 142
Table 53. Catalent Inc.: Business Segmentation in 2018 143
Table 54. Catalent Inc.: Product Portfolio 143
Table 55. Catalent Inc.: Revenue, 2018-2020, $ million 144
Table 56. Catalent Inc.: Revenue by Region in 2018 144
Table 57. Dr. Reddy's Laboratories: Company Snapshot 145
Table 58. Dr. Reddy's Laboratories: Business Segmentation 145
Table 59. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn 146
Table 60. F. Hoffmann-La Roche: Company Snapshot 147
Table 61. F. Hoffmann-La Roche: Business Segmentation 148
Table 62. GlaxoSmithKline: Company Snapshot 149
Table 63. GlaxoSmithKline: Business Segmentation 150
Table 64. GlaxoSmithKline: Product Portfolio 151
Table 65. GlaxoSmithKline: Revenue, 2018-2020, $ bn 152
Table 66. Lonza Group: Company Snapshot 154
Table 67. Lonza Group: Business Segmentation in 2018 155
Table 68. Lonza Group: Product Portfolio 155
Table 69. Lonza Group: Revenue by Region in 2018 156
Table 70. Lupin Limited: Company Snapshot 159
Table 71. Lupin Limited: Business Segmentation 159
Table 72. Merck & Co., Inc.: Company Snapshot 162
Table 73. Merck & Co., Inc.: Business Segmentation 162
Table 74. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 163
Table 75. Mylan NV: Company Snapshot 165
Table 76. Mylan NV: Revenue, 2017-2019, $ bn 166
Table 77. Novartis International AG: Company Snapshot 168
Table 78. Novartis International AG: Business Segmentation 168
Table 79. Novartis International AG: Revenue, 2017-2019, $ bn 169
Table 80. Pfizer Inc.: Company Snapshot 171
Table 81. Pfizer Inc.: Business Segmentation 172
Table 82. Pfizer Inc.: Product Portfolio 173
Table 83. Pfizer Inc.: Revenue, 2018-2020, $ bn 173
Table 84. Sanofi: Company Snapshot 176
Table 85. Sanofi: Business Segmentation 176
Table 86. Sanofi: Revenue, 2018-2020, $ bn 177
Table 87. Sun Pharmaceutical Industries Limited: Company Snapshot 179
Table 88. Teva Pharmaceutical Industries Ltd.: Company Snapshot 182
Table 89. Teva Pharmaceutical Industries Ltd.: Business Segmentation 183
Table 90. Thermo Fisher Scientific: Company Snapshot 184
Table 91. Risk Evaluation for Investing in Asia Pacific Market, 2021-2028 187
Table 92. Critical Success Factors and Key Takeaways 190
